BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18461312)

  • 21. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease.
    Fogdell-Hahn A; Ligers A; Grønning M; Hillert J; Olerup O
    Tissue Antigens; 2000 Feb; 55(2):140-8. PubMed ID: 10746785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population.
    Huang HS; Peng JT; She JY; Zhang LP; Chao CC; Liu KH; She JX
    Hum Immunol; 1995 Dec; 44(4):210-9. PubMed ID: 8770634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips.
    Gödde R; Rohde K; Becker C; Toliat MR; Entz P; Suk A; Müller N; Sindern E; Haupts M; Schimrigk S; Nürnberg P; Epplen JT
    J Mol Med (Berl); 2005 Jun; 83(6):486-94. PubMed ID: 15770496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DR and -DQ associations with multiple sclerosis in Turkey.
    Saruhan-Direskeneli G; Esin S; Baykan-Kurt B; Ornek I; Vaughan R; Eraksoy M
    Hum Immunol; 1997 Jun; 55(1):59-65. PubMed ID: 9328791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis and HLA class II susceptibility and resistance genes.
    Haegert DG; Michaud M; Schwab C; Francis GS
    J Neurosci Res; 1990 May; 26(1):66-73. PubMed ID: 1972763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis.
    Spurkland A; Rønningen KS; Vandvik B; Thorsby E; Vartdal F
    Hum Immunol; 1991 Jan; 30(1):69-75. PubMed ID: 2001977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer.
    Spurkland A; Celius EG; Knutsen I; Beiske A; Thorsby E; Vartdal F
    Tissue Antigens; 1997 Jul; 50(1):15-22. PubMed ID: 9243750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients.
    Teutsch SM; Bennetts BH; Buhler MM; Heard RN; Stewart GJ
    Hum Immunol; 1999 Aug; 60(8):715-22. PubMed ID: 10439317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TAP2 polymorphisms in Australian multiple sclerosis patients.
    Bennetts BH; Teutsch SM; Heard RN; Dunckley H; Stewart GJ
    J Neuroimmunol; 1995 Jun; 59(1-2):113-21. PubMed ID: 7797612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15.
    Traherne JA; Barcellos LF; Sawcer SJ; Compston A; Ramsay PP; Hauser SL; Oksenberg JR; Trowsdale J
    Hum Mol Genet; 2006 Jan; 15(1):155-61. PubMed ID: 16321988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of multiple sclerosis.
    Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 1997; 6(10):1693-8. PubMed ID: 9300661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population.
    Balducci-Silano PL; Layrisse Z; Dominguez E; Amaro R; Gunczler P; Lanes R; Zaro R
    Eur J Immunogenet; 1994 Dec; 21(6):405-14. PubMed ID: 9098450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class II polymorphism in Latin American patients with multiple sclerosis.
    Rojas OL; Rojas-Villarraga A; Cruz-Tapias P; Sánchez JL; Suárez-Escudero JC; Patarroyo MA; Anaya JM
    Autoimmun Rev; 2010 Apr; 9(6):407-13. PubMed ID: 19896562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients.
    Stewart GJ; Teutsch SM; Castle M; Heard RN; Bennetts BH
    Eur J Immunogenet; 1997 Apr; 24(2):81-92. PubMed ID: 9104579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism and distribution of HLA-DR2 alleles in Mexican populations.
    Vargas-Alarcón G; Hernández-Pacheco G; Gamboa R; Zuñiga J; Flores C; Gomez-Casado E; Martínez-Laso J; Granados J; Arnaiz-Villena A
    Hum Immunol; 2001 Mar; 62(3):286-91. PubMed ID: 11250046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the non-HLA-DR-DQ contribution to IDDM1 in British Caucasian families: analysis of LMP7 polymorphisms.
    McTernan CL; Stewart LC; Mijovic CH; Barnett AH
    Diabet Med; 2000 Sep; 17(9):661-6. PubMed ID: 11051286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
    Hillert J; Olerup O
    Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restriction fragment length polymorphism analysis of HLA-DR- and DQ-linked alleles in multiple sclerosis in Spain.
    Clerici N; Fernández M
    J Neuroimmunol; 1992 Dec; 41(2):245-8. PubMed ID: 1361490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.